8-K: Veeva Systems Appoints Brian Van Wagener as Chief Financial Officer

Sentiment:

Executive Appointment Announcement


Veeva Systems has appointed Brian Van Wagener as its new Chief Financial Officer, effective September 16, 2024, succeeding Tim Cabral who will remain on the Board of Directors.

Summary

  • Veeva Systems has appointed Brian Van Wagener as Chief Financial Officer, effective September 16, 2024.
  • Mr. Van Wagener previously served as Executive Vice President, Finance at Veeva.
  • He brings 20 years of experience in technology, healthcare, and life sciences.
  • Prior to his return to Veeva, he was SVP, GTM Strategy and Operations at BetterUp.
  • His previous roles at Veeva include VP, Global Sales Operations, Chief People Officer, and Chief of Staff to the CEO.
  • Mr. Van Wagener's annual base salary will be $450,000.
  • He received several equity grants, including restricted stock units and stock options, with varying vesting schedules.
  • Tim Cabral has resigned as Interim Chief Financial Officer but will remain on the Veeva Board of Directors.

Sentiment

Score: 7

Explanation: The document reflects a positive change with the appointment of a new CFO with a strong background and history with the company. The transition appears smooth, and the compensation package is in line with expectations. There are no significant negative aspects mentioned.

Positives

  • The appointment of Brian Van Wagener brings a seasoned executive with 20 years of experience in relevant sectors.
  • Mr. Van Wagener has a strong history with Veeva, having held multiple key roles within the company.
  • The transition appears smooth, with the outgoing CFO remaining on the board.
  • The equity grants provide a strong incentive for Mr. Van Wagener to contribute to the company's long-term success.

Risks

  • The transition of the CFO role could present some short-term operational risks.
  • The vesting of the equity grants is subject to Mr. Van Wagener's continued service, which could be a risk if he were to leave the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the appointment and compensation details of the new CFO.

Management Comments

  • The company is pleased to offer Brian Van Wagener the position of Executive Vice President, Finance, with the expectation that he will be appointed Chief Financial Officer after a transition period.
  • The company has offered Brian Van Wagener an annual base salary of $450,000.
  • The company has granted Brian Van Wagener equity compensation including restricted stock units and stock options.

Industry Context

The appointment of a new CFO is a standard corporate event, but the fact that the appointee has a strong history with the company and relevant industry experience suggests a focus on stability and continuity. The life sciences and technology sectors are competitive, and a strong financial leader is crucial for success.

Comparison to Industry Standards

  • The compensation package for the new CFO, including a $450,000 base salary and significant equity grants, is consistent with industry standards for executive roles in publicly traded technology and life sciences companies.
  • Companies like Salesforce, Workday, and ServiceNow, which operate in similar sectors, often provide comparable compensation packages to their CFOs, including a mix of base salary, bonuses, and equity.
  • The vesting schedules for the equity grants are also typical, with a mix of short-term and long-term vesting periods to incentivize both immediate and sustained performance.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerTim Cabral (Interim)Brian Van WagenerSeptember 16, 2024Appointment of new CFO

Stakeholder Impact

  • Shareholders may view the appointment of a new CFO with relevant experience as a positive development.
  • Employees may experience changes in leadership and reporting structures within the finance department.
  • Customers and suppliers are unlikely to be directly impacted by this change.

Next Steps

  • Brian Van Wagener will assume the role of Chief Financial Officer on September 16, 2024.
  • The company will likely issue further communications regarding the transition and any strategic changes.

Key Dates

DateDescription
May 23, 2024Date of Brian Van Wagener's offer letter.
August 1, 2024Vesting start date for some of Brian Van Wagener's equity grants.
September 11, 2024Date of the board of directors' appointment of Brian Van Wagener as CFO.
September 16, 2024Effective date of Brian Van Wagener's appointment as CFO and Tim Cabral's resignation as Interim CFO.
January 1, 2025First vesting date for a portion of Brian Van Wagener's RSU grant.
April 1, 2025Second vesting date for a portion of Brian Van Wagener's RSU grant.
August 1, 2028Vesting date for additional RSU and stock option grants for Brian Van Wagener.

Keywords

Chief Financial Officer, CFO, Brian Van Wagener, Veeva Systems, Executive Appointment, Equity Grants, Stock Options, Restricted Stock Units, Tim Cabral, Management Change

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.